Chandan Healthcare’s first quarter of FY27 shows significant profit and margin increases, bolstered by broader diagnostics network, government collaborations, and strategic expansion plans across India.
Chandan Healthcare has reported a sharp rise in profit and margins for the first quarter of FY27, helped by a broader diagnostics network, stronger government business and progress in partnership-led expansion. The Lucknow-based company said total income rose 19.62% year on year to ₹82.26 crore, while EBITDA increased 42.27% to ₹20.98 crore. Net profit climbed 29.51% to ₹7.50 crore, and the EBITDA margin improved to 25.51%. According to the company, the quarter also delivered stronger sequential growth, with income, profit and earnings per share all improving from the previous quarter.
The results come alongside evidence of fast operational scaling. In an accompanying update reported by The Tribune and Medical Buyer, Chandan Healthcare said operating income rose 35.64% year on year to ₹48.67 crore, while its pharmacy arm posted 13.69% growth to ₹32.33 crore. The company attributed the gains to higher patient volumes and gains across its B2B, B2C and government businesses, suggesting that its revenue mix is becoming more diversified as the network expands.
Amar Singh, the company’s promoter, chairman and managing director, said the quarter reflected steady execution across the group’s growth channels. He said Chandan added 134 franchise centres during the period, taking its franchise count to 264, and expanded its total network to 327 centres after opening one comprehensive diagnostic centre, two diagnostic centres and three standalone laboratories. Singh also said the purchase of Nishkam Imaging in New Delhi strengthened the capital’s network, while a new centre in Vadodara marked the company’s entry into Gujarat.
The company’s broader expansion plan appears ambitious. A report on Arthneeti said Chandan is targeting five comprehensive centres and 20 standalone labs in FY27, with a longer-term aim of reaching all districts in Uttar Pradesh and Uttarakhand before moving into other states. The same report said the franchise network is expected to grow sharply over the next two years, while new initiatives such as direct-to-consumer digital services, home sample collection, PET scans and a genome laboratory could add further growth drivers. It also said government PPP projects in Punjab, Haryana and Assam are expected to begin contributing from the second quarter.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
